UBS lowered the firm’s price target on AMN Healthcare (AMN) to $25.50 from $30 and keeps a Neutral rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMN:
- AMN Healthcare Services: Strong Performance and Optimistic Outlook Justify Buy Rating
- AMN Healthcare’s Mixed Earnings Call: Achievements and Challenges
- AMN Healthcare Services: Stabilization Amidst Challenges and Cautious Hold Rating
- AMN Healthcare Reports Q1 2025 Financial Results
- AMN Healthcare sees Q2 revenue $645M-$660M, consensus $648.92M
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue